Chromatographia

, Volume 50, Issue 7–8, pp 407–414 | Cite as

Synthesis and properties of molecular imprints of darifenacin: The potential of molecular imprinting for bioanalysis

  • R. F. Venn
  • R. J. Goody
Originals
Received:
Revised:
Accepted:

Summary

A molecularly imprinted polymer has been developed which subsequently demonstrated an ability to selectively retain darifenacin (UK-88, 525-S) from aqueous acetonitrile when used as a stationary phase in HPLC columns and as a packing in solid-phase extraction cartridges.

The imprinted polymer is applicable to a wide range of analytical methods including extraction from plasma, purification of radiolabelled UK-88,525, chiral separations and separation of metabolites and structural analogues. The polymer is able to extract darifenacin directly from a protein-precipitated human plasma/acetonitrile (1:1 v/v) mixture with 100% recovery. The imprinted polymer can also effect a repurification of14C-labelled darifenacin.

The drawbacks of molecular imprints for ultra-trace bioanalysis (in the sub-nanogram/mL range) are discussed. These centre on the difficulty of removing all the template from the polymer and the consequent effects of template bleed on assay precision and accuracy when used as solid-phase extraction cartridges. Possible solutions to this problem are considered.

Key Words

Column liquid chromatography Solid-phase extraction Molecular imprinting Bioanalysis 
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. [1]
    G. Vlatakis, L. I. Andersson, R. Mueller, K. Mosbach, Nature (London)361, 645 (1993).CrossRefGoogle Scholar
  2. [2]
    I. A. Nicholls, J. Matsui, M. Krook, K. Mosbach, J. Mol. Recognit.9, 652 (1996).CrossRefGoogle Scholar
  3. [3]
    G. Wulff, T. Gross, R. Schonfeld, Angew. Chem. Int. Ed. Engl.36, 1962 (1997).CrossRefGoogle Scholar
  4. [4]
    J. Berglund, C. Lindbladh, K. Mosbach, I. A. Nicholls, Anal. Commun.35, 3 (1998).CrossRefGoogle Scholar
  5. [5]
    O. Ramström, C. Yu, K. Mosbach, J. Mol. Recognit.9, 691 (1996).CrossRefGoogle Scholar
  6. [6]
    S. H. Cheong, S. McNiven, A. Rachkov, R. Levi, K. Yano, I. Karube, Macromolecules30, 1317 (1997).CrossRefGoogle Scholar
  7. [7]
    D. Kriz, K. Mosbach, Analytica Chimica Acta300, 1 (1995).CrossRefGoogle Scholar
  8. [8]
    M. Kempe andK. Mosbach, J. Chromatogr.A, 694, 3 (1995).CrossRefGoogle Scholar
  9. [9]
    M. Kempe, K. Mosbach, J. Chromatogr.A 664, 276 (1994).CrossRefGoogle Scholar
  10. [10]
    K. Nilsson, J. Lindell, O. Norrlow, B. Sellergren, J. Chromatogr.A 680, 57 (1994).CrossRefGoogle Scholar
  11. [11]
    F. Svec, J. M. J. Fréchet, Analytical Chemistry64, 820 (1992).CrossRefGoogle Scholar
  12. [12]
    M. Kempe, K. Mosbach, J. Chromatogr.A 691, 317 (1995).CrossRefGoogle Scholar
  13. [13]
    D. Kriz, C. B. Kriz, L. I. Andersson, K. Mosbach, Anal. Chem.66 2636 (1994).CrossRefGoogle Scholar
  14. [14]
    V. A. Alabaster, Life Sci.60, 1053 (1997).CrossRefGoogle Scholar
  15. [15]
    A. Graul, J. Castaner, Drugs Future21, 1105 (1996).Google Scholar
  16. [16]
    K. C. Beaumont, N. J. Cussans, D. J. Nichols, D. A. Smith, Xenobiotica28, 63 (1998).CrossRefGoogle Scholar
  17. [17]
    B. Kaye, W. J. Herron, P. V. Macrae, S. Robinson, D. A. Stopher, R. F. Venn, W. Wild, Analytical Chemistry,68, 1658 (1996).CrossRefGoogle Scholar
  18. [18]
    L. I. Andersson, D. J. O'Shannessy, K. J. Mosbach, Chromatogr.513, 167 (1990).CrossRefGoogle Scholar
  19. [19]
    R. Mueller, L. I. Andersson, K. Mosbach, Makromol. Chem., Rapid Commun.14, 637 (1993).CrossRefGoogle Scholar
  20. [20]
    H. S. Andersson, “Towards the rational design of molecularly imprinted polymers”, Doctoral Thesis, 1999, Kalmar University and Lund University, Sweden.Google Scholar
  21. [21]
    L. I. Andersson, A. Paprica, T. Arvidsson, Chromatographia46, 57 (1997).CrossRefGoogle Scholar
  22. [22]
    L. I. Andersson, in Methodol. Surv. Bioanal. Drugs 25 (Drug Development Assay Approaches), E. Reid, H. M. Hill and I. D. Wilson, Eds. (1998), p. 2Google Scholar
  23. [23]
    A. Zander, P. Findlay, T Renner, B. Sellergren, A. Swietlow, Anal. Chem.,70, 304 (1998).CrossRefGoogle Scholar

Copyright information

© Friedr. Vieweg & Sohn Verlagsgesellschaft mbH 1999

Authors and Affiliations

  • R. F. Venn
    • 1
  • R. J. Goody
    • 1
  1. 1.Department of Drug MetabolismPfizer Central ResearchSandwichUK

Personalised recommendations